These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7847816)

  • 1. Evidence for the involvement of sulfhydryl groups in the expression of antitumor activity of streptococcal acid glycoprotein (SAGP) purified from crude extract of Streptococcus pyogenes.
    Yoshida J; Takamura S; Suzuki S
    Anticancer Res; 1994; 14(5A):1833-7. PubMed ID: 7847816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative and apoptosis-inducing effects of an antitumor glycoprotein from Streptococcus pyogenes.
    Yoshida J; Takamura S; Ishibashi T; Nishio M
    Anticancer Res; 1999; 19(3A):1865-71. PubMed ID: 10470129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a streptococcal antitumor glycoprotein (SAGP).
    Yoshida J; Takamura S; Nishio M
    Life Sci; 1998; 62(12):1043-53. PubMed ID: 9519806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of streptococcal acid glycoprotein produced by Streptococcus pyogenes Su.
    Kanaoka M; Fukita Y; Taya K; Kawanaka C; Negoro T; Agui H
    Jpn J Cancer Res; 1987 Dec; 78(12):1409-14. PubMed ID: 3123442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor.
    Yoshida J; Ishibashi T; Nishio M
    Cancer Res; 2001 Aug; 61(16):6151-7. PubMed ID: 11507066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of an antitumor principle from Streptococcus hemolyticus, Su strain.
    Yoshida J; Yoshimura M; Takamura S; Kobayashi S
    Jpn J Cancer Res; 1985 Mar; 76(3):213-23. PubMed ID: 3922840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor action of an acidic glycoprotein (SAGP) from Streptococcus pyogenes in mice.
    Yoshida J; Takamura S; Suzuki S
    Biotherapy; 1991; 3(4):331-6. PubMed ID: 1786196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcal antitumor protein: expression in Escherichia coli cells and properties of the recombinant protein.
    Kanaoka M; Negoro T; Kawanaka C; Agui H; Nabeshima S
    Agric Biol Chem; 1991 Mar; 55(3):743-50. PubMed ID: 1368629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein.
    Yoshida J; Takamura S; Suzuki S; Nishio M
    Br J Cancer; 1996 Apr; 73(8):917-23. PubMed ID: 8611426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell growth-inhibitory action of SAGP, an antitumor glycoprotein from Streptococcus pyogenes (Su strain).
    Yoshida J; Takamura S; Suzuki S
    Jpn J Pharmacol; 1987 Oct; 45(2):143-7. PubMed ID: 3325668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified method for purification of an antitumor acidic glycoprotein from Streptococcus pyogenes (Su strain) by immunoadsorbent chromatography.
    Yoshida J; Takamura S; Suzuki S
    J Antibiot (Tokyo); 1989 Mar; 42(3):448-53. PubMed ID: 2651374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the arginine deiminase of Streptococcus equi subsp. zooepidemicus.
    Hong K
    Can J Microbiol; 2006 Sep; 52(9):868-76. PubMed ID: 17110979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic and antitumor effect of a fraction from cell-free extract of group A Streptococcus on transplantable tumor cells.
    Higuchi Y; Shoin S
    Anticancer Res; 1987; 7(6):1251-6. PubMed ID: 3327452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.
    Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
    Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of group A streptococcal acid glycoprotein on expression of major virulence factors and internalization by epithelial cells.
    Marouni MJ; Ziomek E; Sela S
    Microb Pathog; 2003 Aug; 35(2):63-72. PubMed ID: 12901845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of apoptosis and inhibition of AP-1 activity by TAC-101 (4-[3,5-bis(trimethylsilyl) benzamido] benzoic acid) may result in life prolonging effect in animals bearing metastasizing cancer.
    Shibata J; Murakami K; Aoyagi Y; Oie S; Hashimoto A; Suzuki K; Sano M; Wierzba TT; Yamada Y
    Anticancer Res; 2000; 20(5B):3583-90. PubMed ID: 11131666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of a refined polysaccharide peptide fraction isolated from Coriolus versicolor: in vitro and in vivo studies.
    Dong Y; Kwan CY; Chen ZN; Yang MM
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):140-8. PubMed ID: 8774067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro direct antiproliferative activity and in vivo antitumor activity of bropirimine against bladder cancer].
    Tahara M; Nomura S; Takahashi M; Takagi H; Hashimoto M; Eto H; Kamidono S
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1039-44. PubMed ID: 8687218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.